The EU Pharma Package: Key Reforms for Pharmaceutical Companies
November 18, 2026
The EU Pharma Package: Key Reforms for Pharmaceutical CompaniesNovember 18, 2026 How the EU’s pharmaceutical reform changes regulatory protection, medicine supply, generic entry, antimicrobial incentives and orphan exclusivity Why should I read this?The European Union is close to completing the most significant overhaul of its pharmaceutical legislation in more than two decades. In September 2026, the Council adopted its first-reading position on the EU Pharma Package, which is made up of a new Directive establishing a Union code for medicinal products for human use and a new Regulation on Union authorisation procedures and the European Medicines Agency. The new framework has two main goals: to make the sector more competitive and to make it more accountable.
What should I do?
Time is running short for companies, regulators, hospitals and Member States to get ready. What else do I need to know about the EU Pharma Package?The package aims to balance several objectives: maintaining the competitiveness of the European pharmaceutical industry, rewarding innovation, preventing medicine shortages, and improving patient access to treatments across the EU.
Given how long ago the last major revision of EU pharmaceutical legislation took place, this package is a substantial step forward, particularly considering that the market has changed profoundly since then. Once formally adopted and published in the Official Journal, Member States will be required to transpose the Directive into national law, while the Regulation will apply directly. Both are expected to apply 24 months after entry into force. For more information on the EU Pharma PackageFurther reading on the EU Pharma PackageGlobal Life Sciences & Healthcare Bulletin The future of the UK life sciences sector: Balancing innovation and regulation Latest InsightsLatest News
Latest Events
legal updates November 18, 2026 UK: FCA releases new ESG ratings rules legal updates November 18, 2026 UK: AI Transcription – harness benefits, manage risks legal updates November 18, 2026 Commercially Connected shorts - 18 November 2026 legal updates November 18, 2026 COP31: Oceans, nature and land use gain ground in climate policy and inves... deal alerts November 06, 2026 Eversheds Sutherland advises Mercedes-Benz on European fast-charging partne... firm news November 05, 2026 Eversheds Sutherland hires partner Peter Cheng to lead Hong Kong ECM practi... firm news October 27, 2026 Eversheds Sutherland (International) announces senior leadership appointmen... firm news October 26, 2026 Eversheds Sutherland deepens fintech and regulatory bench with double partn... hybrid Europe Action Week 2026 Europe Action Week returns this November with a dynamic mix of events designed to help you navigate what’s next. in-person Industrial relations masterclass November 18, 2026 9.30am - 4.30pm (GMT) London, United Kingdom virtual Education Webinar - Equality, diversity and inclusion: current developments... November 18, 2026 11:00AM - 12:00PM virtual Education Webinar - Protecting your IP when contracting with third parties ... November 19, 2026 11:00AM - 12:00PM |